## Abstract ## Background Vascular endothelial growth factor (VEGF) is recognized as an important stimulator of angiogenesis. Formation of new blood vessels by angiogenic factors occurs in many biological processes, both physiological and pathological, among others in growth of primary solid malig
Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma
β Scribed by Akira Mitsuhashi; Kiyomi Suzuka; Koji Yamazawa; Hideo Matsui; Katsuyoshi Seki; Souei Sekiya
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 111 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND To the authors' knowledge, little is known to date regarding the prognostic relevance of measuring serum levels of vascular endothelial growth factor (VEGF), a potent stimulator of angiogenesis, in patients with colon carcinoma who undergo surgery. ## METHODS Preoperati
I read with interest the article by Kettritz et al. 1 regarding the accuracy of stereotactic 11-gauge vacuum-assisted breast biopsy (VAB) for diagnosing breast cancer in nonpalpable breast lesions. Of the 2893 VAB procedures performed, 19 (0.7%) yielded findings that were not representative, whereas
The angiogenic factor vascular endothelial growth factor (VEGF) predicts outcome in primary breast carcinoma. Alteration of the p53 gene causes down-regulation of the expression of thrombospondin-1, a natural inhibitor of angiogenesis. This study was conducted to investigate the association between
Vascular endothelial growth factor-C (VEGF-C) is a recently characterized member of the VEGF family of angiogenic polypeptides. We demonstrate here that VEGF-C is angiogenic in vitro when added to bovine aortic or lymphatic endothelial (BAE and BLE) cells but has little or no effect on bovine microv